Patents-Review.com
🔗 Permalink
Assignee profile:

THROMBOGENICS NV

City:

Leuven

Country:

Belgium

Published Applications:

14

Last publication date:

2019-01-31

Patent Grants:

12

Last grant date:

2017-09-26

Top Inventors for applications by THROMBOGENICS NV

These are the the leading inventors for applications assigned to THROMBOGENICS NV:

Recent patent applications by THROMBOGENICS NV

THROMBOGENICS NV based in Leuven, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-01-31
US20190031762A1
Chemistry; metallurgy

POSTERIOR OCULAR FIBROSIS INHIBITION BY ANTAGONIZING PLACENTAL GROWTH FACTOR

 #2 | 2015-03-05 ✅ Patent 9,770,494 granted on 2017-09-26
US20150064161A1
Human necessities

Pharmacological vitreolysis

 #3 | 2014-06-26 ✅ Patent 9,085,617 granted on 2015-07-21
US20140178397A1
Chemistry; metallurgy

Anti-angiogenic therapy

 #4 | 2014-04-10 ✅ Patent 8,993,323 granted on 2015-03-31
US20140099710A1
Chemistry; metallurgy

Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells

 #5 | 2013-11-14 ✅ Patent 9,186,394 granted on 2015-11-17
US20130302304A1
Human necessities

Pharmacological vitreolysis

 #6 | 2013-08-08
US20130202613A1
Human necessities

PHARMACOLOGICAL VITREOLYSIS

 #7 | 2013-08-01 ✅ Patent 8,834,869 granted on 2014-09-16
US20130195887A1
Human necessities

Pharmacological vitreolysis

 #8 | 2012-05-10 ✅ Patent 9,226,953 granted on 2016-01-05
US20120114630A1
Human necessities

Variants of plasminogen and plasmin

 #9 | 2011-12-08 ✅ Patent 8,747,842 granted on 2014-06-10
US20110300123A1
Human necessities

Pharmacological vitreolysis

 #10 | 2011-07-14 ✅ Patent 8,383,105 granted on 2013-02-26
US20110171190A1
Human necessities

Pharmacological vitreolysis

 #11 | 2011-05-26 ✅ Patent 8,758,748 granted on 2014-06-24
US20110123525A1
Chemistry; metallurgy

Anti-angiogenic therapy

 #12 | 2009-04-16 ✅ Patent 8,697,444 granted on 2014-04-15
US20090098650A1
Chemistry; metallurgy

Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells

 #13 | 2008-08-14 ✅ Patent 7,875,704 granted on 2011-01-25
US20080193455A1
Chemistry; metallurgy

Anti-PLGF antibody

 #14 | 2005-06-02 ✅ Patent 7,547,435 granted on 2009-06-16
US20050118158A1
Human necessities

Pharmacological vitreolysis

Also check out ThromboGenics NV's (Leuven, Belgium) applicant profile with 5 patent applications submitted.

AssigneeID:

32624 ⎘